STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
出版年份 2020 全文链接
标题
STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
作者
关键词
-
出版物
Cells
Volume 9, Issue 3, Pages 722
出版商
MDPI AG
发表日期
2020-03-19
DOI
10.3390/cells9030722
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
- (2020) Wook Jin Cells
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- STAT3 and STAT5 Activation in Solid Cancers
- (2019) Sebastian Igelmann et al. Cancers
- A STAT3-based gene signature stratifies glioma patients for targeted therapy
- (2019) Melanie Si Yan Tan et al. Nature Communications
- Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
- (2019) Kim et al. Journal of Clinical Medicine
- Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
- (2019) Christina Piperi et al. Cells
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies
- (2018) Loukik Arora et al. Cancers
- The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas
- (2017) Te Whiti Rogers et al. JOURNAL OF NEURO-ONCOLOGY
- Strategies and Approaches of Targeting STAT3 for Cancer Treatment
- (2016) Steffanie L. Furtek et al. ACS Chemical Biology
- Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment
- (2016) Byung-Hak Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Modes of cancer cell invasion and the role of the microenvironment
- (2015) Andrew G Clark et al. CURRENT OPINION IN CELL BIOLOGY
- Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
- (2015) Cheolhee Won et al. HEPATOLOGY
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway
- (2015) Anwar Hossain et al. STEM CELLS
- Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes
- (2015) Carlo Cusulin et al. Stem Cell Reports
- STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
- (2014) Guo-Shi Lin et al. MEDICAL ONCOLOGY
- STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
- (2014) Jennifer Kim et al. Cancers
- STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
- (2014) Melanie Spitzner et al. Cancers
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
- (2013) P. Mao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for label-retaining tumour-initiating cells in human glioblastoma
- (2011) Loic P. Deleyrolle et al. BRAIN
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3
- (2010) Byung-Hak Kim et al. Molecular Cancer
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin
- (2009) A. Tamase et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started